Cargando…

S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL

Detalles Bibliográficos
Autores principales: Knapper, Steven, Thomas, Abin, King, Sophie, Thomas, Ian, Gilkes, Amanda, Irwin, Sarah, Sellar, Robert, Green, Simone, Overgaard, Ulrik Malthe, Mehta, Priyanka, Dennis, Mike, Freeman, Sylvie, Russell, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428467/
http://dx.doi.org/10.1097/01.HS9.0000967436.08196.70